About this trial
All-comer study of unselected patients suitable for carotid artery revascularization to evaluate the feasibility, efficacy and safety of first line endovascular revasculariztion using MicroNet covered stent (CGuard™) in the treatment of consecutive symptomatic and increased-stroke-risk asymptomatic carotid lesions that require revascularization by Neurovascular Team decision.
Eligibility criteria
Qualifiers
Patient > 18 years old qualified by NeuroVascular Team for carotid revascularization according to local standards of care
Signed informed consent
Agreement (routin un this group of patients) to clinical and ultrasonographis follow up.
De-novo atherosclerotic lesions or neo-atherosclerosis
Disqualifiers
Lack of NeuroVascular Team agreement on carotid revascularization indication
Lack of signed informed consent
Estimated life expectancy less than 1 year
Chronic renal failure with serum creatinine level > 3.0 mg/dL
Trial design
Treatments tested in this trial
- Carotid Artery Stenting
Treatment groups
Sponsors and collaborators
John Paul II Hospital, Krakow
Lead sponsor
Jagiellonian University
Collaborator